Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33961 | 81 | 30.3 | 50% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 310 | 17755 | CARCINOMA RENAL CELL//PARTIAL NEPHRECTOMY//NEPHRECTOMY |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | INTIMA TO MEDIA RATIO | Author keyword | 1 | 50% | 2% | 2 |
| 2 | EPIDEMIOL HLTH BEHAV SOC | Address | 0 | 33% | 1% | 1 |
| 3 | BIOL DOSE SECT | Address | 0 | 20% | 1% | 1 |
| 4 | COLORECTAL ADENOMATOUS POLYPS | Author keyword | 0 | 13% | 1% | 1 |
| 5 | GANG DONG KYUNG HEE UNIV HOSP | Address | 0 | 13% | 1% | 1 |
| 6 | ANTITHROMBOTIC MEDICATION | Author keyword | 0 | 10% | 1% | 1 |
| 7 | ADV HELATH SCI TECHNOL | Address | 0 | 100% | 1% | 1 |
| 8 | BLOOMBERG PIBL HELATH | Address | 0 | 100% | 1% | 1 |
| 9 | CLIN OCCUPAT ENVIRONM MED COPENHAGEN | Address | 0 | 100% | 1% | 1 |
| 10 | D13S153 | Author keyword | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | INTIMA TO MEDIA RATIO | 1 | 50% | 2% | 2 | Search INTIMA+TO+MEDIA+RATIO | Search INTIMA+TO+MEDIA+RATIO |
| 2 | COLORECTAL ADENOMATOUS POLYPS | 0 | 13% | 1% | 1 | Search COLORECTAL+ADENOMATOUS+POLYPS | Search COLORECTAL+ADENOMATOUS+POLYPS |
| 3 | ANTITHROMBOTIC MEDICATION | 0 | 10% | 1% | 1 | Search ANTITHROMBOTIC+MEDICATION | Search ANTITHROMBOTIC+MEDICATION |
| 4 | D13S153 | 0 | 100% | 1% | 1 | Search D13S153 | Search D13S153 |
| 5 | D16S422 | 0 | 100% | 1% | 1 | Search D16S422 | Search D16S422 |
| 6 | D1S216 | 0 | 100% | 1% | 1 | Search D1S216 | Search D1S216 |
| 7 | D3S1217 | 0 | 100% | 1% | 1 | Search D3S1217 | Search D3S1217 |
| 8 | D7S480 | 0 | 100% | 1% | 1 | Search D7S480 | Search D7S480 |
| 9 | D9S157 | 0 | 100% | 1% | 1 | Search D9S157 | Search D9S157 |
| 10 | DYSPLASIA P53 | 0 | 100% | 1% | 1 | Search DYSPLASIA+P53 | Search DYSPLASIA+P53 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | URETER CANCER | 0 | 33% | 1% | 1 |
| 2 | INTERMEDIATE LESIONS | 0 | 25% | 1% | 1 |
| 3 | COPENHAGEN CASE CONTROL | 0 | 10% | 1% | 1 |
| 4 | LOCAL ATHEROSCLEROSIS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| THE ROLE OF MEDROXYPROGESTERONE ACETATE (MPA) IN THE TREATMENT OF RENAL ADENOCARCINOMA | 1988 | 6 | 20 | 65% |
| Should Screening for Colorectal Neoplasm Be Recommended in Patients at High Risk for Coronary Heart Disease A Cross-Sectional Study | 2015 | 0 | 27 | 11% |
| Gastrointestinal malignancies and cardiovascular diseases-Non-negligible comorbidity in an era of multi-antithrombotic drug use | 2011 | 0 | 60 | 8% |
| SYSTEMIC THERAPY OF METASTATIC RENAL-CELL CARCINOMA | 1987 | 16 | 54 | 13% |
| Breast cancer - Interaction between ethnicity and environment | 2000 | 10 | 82 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EPIDEMIOL HLTH BEHAV SOC | 0 | 33% | 1.2% | 1 |
| 2 | BIOL DOSE SECT | 0 | 20% | 1.2% | 1 |
| 3 | GANG DONG KYUNG HEE UNIV HOSP | 0 | 13% | 1.2% | 1 |
| 4 | ADV HELATH SCI TECHNOL | 0 | 100% | 1.2% | 1 |
| 5 | BLOOMBERG PIBL HELATH | 0 | 100% | 1.2% | 1 |
| 6 | CLIN OCCUPAT ENVIRONM MED COPENHAGEN | 0 | 100% | 1.2% | 1 |
| 7 | DEPARTMNE HLTH SCI TECHNOL | 0 | 100% | 1.2% | 1 |
| 8 | DOSE ASSESMENT | 0 | 100% | 1.2% | 1 |
| 9 | EPIDEMIOL CARDIOL EPI CARE | 0 | 100% | 1.2% | 1 |
| 10 | HEALTHCARE GANGNAM FINANCE | 0 | 100% | 1.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000179998 | SERV INTEGRATO EPIDEMIOL SISTEMI INFORMAT//HLTH HLTH SERV//CARCINOMA RENAL CELL |
| 2 | 0.0000135501 | INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//RECOMBINANT INTERLEUKIN 2 |
| 3 | 0.0000115620 | JIANGDA PATHOL//APOPTOTIC EFFECTS//BETA CX |
| 4 | 0.0000107767 | ARTERIOSCLEROTIC PLAQUE//BANK MONTREAL//BENZOAPYRENE DIONE |
| 5 | 0.0000104130 | GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250 |
| 6 | 0.0000101740 | COLORECTAL ADENOMA//COLORECTAL ADENOMAS//RED MEAT |
| 7 | 0.0000092294 | JAPANESE BRAZILIANS//JAPANESE MIGRANTS//PREVALENCE OF DIABETES |
| 8 | 0.0000088464 | INCIDENTAL APPENDECTOMY//INVERSION APPENDECTOMY//CLINICIZZATA CHIRURG GEN 1 |
| 9 | 0.0000087812 | D ROMS TEST//D ROMS//OXIDAT |
| 10 | 0.0000086651 | MUS GENUS//KIDNEY ANDROGEN REGULATED PROTEIN//RENAL INDUCTION |